Fracture, aging, and disease in bone
- PDF / 588,194 Bytes
- 15 Pages / 585 x 783 pts Page_size
- 87 Downloads / 178 Views
G. Balooch Materials Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720; and Department of Preventive & Restorative Dental Sciences, University of California, San Francisco, California 94143
R.O. Ritchiea) Materials Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720; and Department of Materials Science and Engineering, University of California, Berkeley, California 94720 (Received 2 February 2006; accepted 2 March 2006)
From a public health perspective, developing a detailed mechanistic understanding of the well-known increase with age in fracture risk of human bone is essential. This also represents a challenge from materials science and fracture mechanics viewpoints. Bone has a complex, hierarchical structure with characteristic features ranging from nanometer to macroscopic dimensions; it is therefore significantly more complex than most engineering materials. Nevertheless, by examining the micro-/nanostructural changes accompanying the process of aging using appropriate multiscale experimental methods and relating them to fracture mechanics data, it is possible to obtain a quantitative picture of how bone resists fracture. As human cortical bone exhibits rising ex vivo crack-growth resistance with crack extension, its fracture toughness must be evaluated in terms of resistance-curve (R-curve) behavior. While the crack initiation toughness declines with age, the more striking finding is that the crack-growth toughness declines even more significantly and is essentially absent in bone from donors exceeding 85 years in age. To explain such an age-induced deterioration in the toughness of bone, we evaluate its fracture properties at multiple length scales, specifically at the molecular and nano dimensions using vibrational spectroscopies, at the microscale using electron microscopy and hard/soft x-ray computed tomography, and at the macroscale using R-curve measurements. We show that the reduction in crack-growth toughness is associated primarily with a degradation in the degree of extrinsic toughening, in particular involving crack bridging, and that this occurs at relatively coarse size scales in the range of tens to hundreds of micrometers. Finally, we briefly describe how specific clinical treatments, e.g., with steroid hormones to treat various inflammatory conditions, can prematurely damage bone, thereby reducing its fracture resistance, whereas regulating the level of the cytokine Transforming Growth Factor- can offer significant improvements in the stiffness, strength, and toughness of bone and as such may be considered a therapeutic target to treat increased bone fragility induced by aging, drugs, and disease.
I. INTRODUCTION
The structural integrity of mineralized tissues such as human bone and teeth is clearly of particular clinical importance, especially in the case of bone, which forms the body’s protective load-bearing skeletal framework. Bone is unique when compared to structural engineering
a)
Address all correspondence to th
Data Loading...
